Should we lose hope in adjuvant therapy for neuroendocrine tumors?—In response to: Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit

Journal of Surgical OncologyVolume 122, Issue 3 p. 570-571 LETTER TO THE EDITOR Should we lose hope in adjuvant therapy for neuroendocrine tumors?—In response to: Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit Giuseppe Lamberti MD, Corresponding Author Giuseppe Lamberti MD lamberti.giu88@gmail.com orcid.org/0000-0003-3069-7630 Department of Experimental, Diagnostic...